Discover 2,121 paid clinical trials in Toronto, Ontario. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,121
Effects of MET-3 and MET-5 on Gut Microbiome and Metabolic Function in Men and Women With Hypertriglyceridemia
for
Obesity, Metabolically Benign
Location: Toronto
Sponsor: NuBiyota
Sex: All
Age: 18 - 49
Code: NCT04507971
Phase 1, Recruiting
Trial of a Virtual Exercise-based Rehabilitation Program to Treat Persistent Chemotherapy-Induced Peripheral Neuropathy (CIPN)
for
Chemotherapy-induced Peripheral Neuropathy (CIPN)
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT07481149
Phase 3, Recruiting
Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)
for
Osteogenesis Imperfecta (OI)
Location: Toronto, Wilmington DE, New Haven CT, Indianapolis IN,
Sponsor: Angitia Incorporated Limited
Sex: All
Age: 18 - 70+
Code: NCT07062588
Phase 2, Recruiting
New
Genome Analysis Across Populations in Inflammatory Bowel Disease
for
Ulcerative Colitis, Healthy, Crohn Disease,
Location: Toronto
Sponsor: Mount Sinai Hospital, Canada
Sex: All
Age: 0+
Code: NCT06042387
Recruiting
Albumin To Enhance Recovery After Acute Kidney Injury
Location: Toronto, North York, St. Catharines, Hamilton, Kingston,
Sponsor: Ottawa Hospital Research Institute
Sex: All
Age: 18+
Code: NCT04705896
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With Hypercholesterolaemia
for
Hypercholesterolaemia
Location: Toronto, North York, Mississauga, Stoney Creek, Guelph,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07619118
Phase 3, Recruiting
New
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
for
Obesity or Overweight, Diabetes Mellitus, Type 2
Location: Toronto, North York, Stouffville, Quebec, Norfolk VA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07784270
Phase 3, Recruiting
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
for
HER2-positive Gastric Cancer,
Location: Toronto, Barrie, Detroit MI, Albany NY, Montreal,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06764875
Phase 3, Recruiting
Modified Deep Extubation vs. Standard Awake Extubation
for
Extubation
Location: Toronto
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Sex: All
Age: 0+
Code: NCT06318715
Recruiting
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Toronto, London, Kingston, Pittsburgh PA, Ann Arbor MI,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06129864
Phase 3, Recruiting
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
for
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Location: Toronto, New York NY, Richmond VA, Chicago IL,
Sponsor: AstraZeneca
Sex: All
Age: 12+
Code: NCT06137118
Phase 1, Phase 2, Recruiting
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer